Skip to main content
. 2020 Oct 27;92(2):165–171. doi: 10.1136/jnnp-2020-323271

Figure 1.

Figure 1

King’s and MiToS stages at study entry. Percentages of patients in each treatment arm corresponding to each clinical stage are shown (edaravone, blue columns; placebo, yellow columns). ALS, amyotrophic lateral sclerosis; MiToS, Milano-Torino staging.